CHASE WILLIAM J

CIK 00015635723 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001563572

Recent Transactions

50 trades

Award
GRAIL, Inc.$GRAL
Common Stock
2026-01-15$97.44/sh+213→ 36,803 total
Award
GRAIL, Inc.$GRAL
Common Stock
2025-10-15$75.52/sh+275→ 36,590 total
Purchase
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-08-20$10.03/sh+100,000→ 134,693 total
Award
GRAIL, Inc.$GRAL
Common Stock
2025-07-15$38.53/sh+533→ 36,315 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-06-11+8,000→ 34,693 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2025-06-11+11,450→ 11,450 total
Award
GRAIL, Inc.$GRAL
Common Stock
2025-05-29$41.10/sh+6,082→ 35,782 total
Award
GRAIL, Inc.$GRAL
Common Stock
2025-04-15$25.94/sh+784→ 29,700 total
Award
GRAIL, Inc.$GRAL
Common Stock
2025-01-15$17.58/sh+1,182→ 28,916 total
Award
GRAIL, Inc.$GRAL
Common Stock
2024-10-30$13.62/sh+210→ 27,734 total
Award
GRAIL, Inc.$GRAL
Common Stock
2024-10-15$14.01/sh+1,054→ 27,524 total
Award
GRAIL, Inc.$GRAL
Common Stock
2024-06-25+26,470→ 26,470 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2024-06-12+11,515→ 11,515 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-06-12+7,737→ 26,693 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-06-14+1,673→ 18,956 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2023-06-14+2,447→ 2,447 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-04-14+10,483→ 17,283 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (Right to Buy)
2023-04-14+14,931→ 14,931 total
Purchase
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2019-06-26$67.30/sh+30,400→ 169,552 total
Tax Payment
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2019-02-28$79.41/sh−27,276→ 139,152 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2019-02-21+14,989→ 157,947 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2019-02-21+15,945→ 142,958 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2019-02-21+8,481→ 166,428 total
Award
AbbVie Inc.$ABBV
Option (right to buy)
2019-02-21+60,747→ 60,747 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2019-02-21+22,150→ 127,013 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2018-12-12$90.00/sh−60,000→ 104,863 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2018-03-01$24.21/sh+19,000→ 197,263 total
Sale
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2018-03-01$114.50/sh−32,400→ 164,863 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2018-03-01$28.31/sh+13,400→ 178,263 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (right to buy)
2018-03-01−19,000→ 0 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (right to buy)
2018-03-01−13,400→ 0 total
Sale
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2018-02-28$119.44/sh−38,528→ 164,863 total
Tax Payment
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2018-02-28$118.26/sh−28,407→ 203,391 total
Award
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2018-02-15+17,319→ 216,807 total
Award
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2018-02-15+14,991→ 231,798 total
Award
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2018-02-15+15,945→ 199,488 total
Award
AbbVie Inc.$ABBV
Option (right to buy)
2018-02-15+45,840→ 45,840 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2017-05-18$28.86/sh+25,500→ 209,043 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (right to buy)
2017-05-18−25,500→ 0 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (right to buy)
2017-05-18−12,800→ 0 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2017-05-18$28.13/sh+12,800→ 221,843 total
Sale
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2017-05-18$65.35/sh−38,300→ 183,543 total
Tax Payment
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2017-02-28$62.22/sh−40,212→ 183,543 total
Award
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2017-02-16+35,440→ 207,810 total
Award
AbbVie Inc.$ABBV
Option (right to buy)
2017-02-16+100,100→ 100,100 total
Award
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2017-02-16+15,945→ 223,755 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2016-12-02$27.29/sh+6,600→ 178,970 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (right to buy)
2016-12-02−6,600→ 0 total
Sale
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2016-12-02$59.19/sh−6,600→ 172,370 total
Tax Payment
AbbVie Inc.$ABBV
Common stock, $0.01 par value
2016-02-29$56.00/sh−45,658→ 172,370 total

CHASE WILLIAM J

Recent Transactions

Companies

Recent Filings

Address